Cargando…
Cellular Therapy Updates in B-Cell Lymphoma: The State of the CAR-T
SIMPLE SUMMARY: B-cell lymphomas are the most commonly occurring blood cancer and the second leading cause of cancer-related death among blood cancers. Chemotherapy and stem cell transplantation have long served as the standard therapies for relapsed or refractory aggressive B-cell lymphomas with ve...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533939/ https://www.ncbi.nlm.nih.gov/pubmed/34680329 http://dx.doi.org/10.3390/cancers13205181 |